Rhythm Pharmaceuticals, Inc. Skyrocketed
Thu, Aug 27, 2020 at 05:30 PM
Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) jumped higher at $23.09, representing a gain of 21%. On Wed 26 Aug 20, RYTM:NASDAQ hit a New 2-Week High of $19.09. The stock appeared on our News Catalysts scanner on Thu 06 Aug 20 at 09:02 AM in the 'MISCELLANEOUS' category. From Wed 12 Aug 20, the stock recorded 60.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
Top 10 Gainers:
- PEDEVCO Corp. (PED:NYSEMKT), 168.72%
- Hermitage Offshore Services Ltd. (PSV:NYSE), 60.05%
- Destination XL Group, Inc. (DXLG:NASDAQ), 55.73%
- AutoWeb, Inc. (AUTO:NASDAQ), 34.92%
- VBI Vaccines Inc. (VBIV:NASDAQ), 32.24%
- Rekor Systems, Inc. (REKR:NASDAQ), 25.98%
- Digital Ally, Inc. (DGLY:NASDAQ), 25.37%
- SunPower Corporation (SPWR:NASDAQ), 23.82%
- BMC Stock Holdings, Inc. (BMCH:NASDAQ), 22.44%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 20.95%